Navigation Links
DiagnoCure announces fourth quarter 2008 and year-end results
Date:12/17/2008

DiagnoCure's non-invasive bladder cancer test, ImmunoCyt(TM) / uCyt+(TM), were $65,402 for the fourth quarter of 2008 versus $79,085 for the same period a year ago. Also in this quarter, DiagnoCure sold clinical samples to Gen-Probe, in support of their prostate cancer testing R&D, for an amount of $58,441 compared with $13,911 in the fourth quarter of 2007.

Interest income decreased $90,269 to $267,659 for the fourth quarter of 2008 compared with $357,928 for the fourth quarter of 2007. The decrease is attributable to DiagnoCure's use of fund to finance the operating activities and the reduction of interest yield in its investments.

Cost of sales increased $15,819 from $62,875 for the fourth quarter of 2007 to $78,694 for the fourth quarter of 2008. This increase is related to higher samples sales.

Based on the above, for the fourth quarter of 2008, DiagnoCure recorded a net loss of $3,568,321, or $0.09 per share, compared with a loss of $3,320,193, or $0.09 per share, for the fourth quarter of 2007. These results are substantially in line with Management expectations and reflect the sales and marketing activities that led to the launch of the Previstage(TM) GCC test in late summer 2008 and the first orders of the test.

    Financial data

    -------------------------------------------------------------------------
                              Three months ended             Years ended
    For the periods of            October 31                  October 31
                       ------------------------------------------------------
                              2008          2007          2008          2007
    -------------------------------------------------------------------------
    Sales                  123,843        94,129       524,564       432,763
    -------------------------------------------------------------------------
    Revenue under
     research and
     license agreeme
'/>"/>
SOURCE DIAGNOCURE INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. DiagnoCures molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings
2. DiagnoCure to host Q2 2008 earnings conference call and webcast
3. DiagnoCure announces second quarter 2008 results
4. DiagnoCures GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group
5. Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test
6. DiagnoCure to present at the JMP Securities Healthcare Focus Conference on October 6, 2008
7. DiagnoCure to webcast presentation at the Piper Jaffray Health Care Conference on December 3, 2008
8. DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... October 30, 2014—(BRONX, NY)—Investigators at Albert Einstein ... and Montefiore Medical Center will present their ... America,s (GSA) 67th Annual Scientific Meeting. Topics include ... survival, risk factors for cognitive impairment and the ... place November 5-9, 2014 in Washington, D.C., "Einstein-Montefiore ...
(Date:10/30/2014)... developed by NIH grantees predicts that women must take ... via vaginal sex, whereas just two doses per week ... This finding helps explain why two large clinical trials ... to show efficacy. Participants in the VOICE ... (another antiretroviral) for HIV prevention were counseled to take ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 High ... exclusive concepts in the medical-grade skin care domain: ... development of uniquely potent topical dermatological products, today ... ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 anti-irritant technology. ... acid concentrations (50% and 70%) and a low ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, ... prostate cancer who also have certain heart problems may increase ... study suggests. , , The therapy in question is called androgen ... levels of male hormones to prevent the growth of cancer ... this hormone therapy was linked to triple the risk of ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Horse ... therapeutic horseback riding to special needs individuals in the ... on Saturday, November 15 from 10-2:00 p.m. at Bailey's ... is open to the public and is designed to ... , Admission to the HSS Round-Up is free. Ticket ...
Breaking Medicine News(10 mins):Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 2Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 3Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 4Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2
... Millions of Americans whose vision is slowly ebbing due to ... the lowly neural progenitor cell may be useful for restoring ... rats, neural progenitor cells derived from human fetal stem cells ... degenerative eye disease similar to the kinds of diseases that ...
... pill to control high blood pressure and new drugs ... Clinic researchers have designed two promising new cardiovascular treatment ... pill form to lower high blood pressure and a ... kidney function. ,In the process, they ...
... the popular anti-clotting drug clopidogrel (Plavix) when taken along with ... adverse bleeding event.// ,The study, to be ... Session on March 27 at 9 am (abstract 1027-18), found ... worsen bleeding after off-pump heart bypass surgery. ...
... multi-center study concludes that women with a recent diagnosis of ... opposite breast.// ,This study was conducted by ... ,The international research team found that MRI, or ... 30 of 969 women (3.1 percent) who had recently been ...
... against a virus that causes cervical cancer.// ,The ... has recommended the universal vaccination of girls aged 12 to ... Health has announced that vaccination of 12 years old girls ... are prepared. ,Government advisors are considering whether ...
... MPs has come together to launch a fight against tuberculosis ... massive awareness drive and also seeking a special fund to ... least two people die of the infectious disease every three ... to form a group next month and to persuade other ...
Cached Medicine News:Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 2Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 3Health News:Hormone-based Heart Pill to Control High Blood Pressure 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 3Health News:Plavix Safe During and After Heart Bypass 2Health News:MRI Screening of Other Breast Crucial for Patients Diagnosed With Cancer in One Breast 2Health News:Indian Parliamentarians Join to Fight Against TB 2
(Date:10/30/2014)... Oct. 30, 2014 CVS Health (NYSE: ... affiliations with three leading regional health systems to enhance access ... health systems include Baptist Health System in Alabama ... Commonwealth Health in Pennsylvania , Northwest Medical ... , and Tennova Healthcare in Tennessee ; ...
(Date:10/30/2014)... , Oct. 30, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... 2014 financial results will be released on Thursday, November ... conference call and live webcast at 1:30 p.m. PST ...
(Date:10/30/2014)... October 30, 2014 , ... LGG contribuye a adquirir tolerancia a la proteína ... la proteína de la leche de la vaca (APLV) ... infancia. Hasta ahora, la APLV se trataba eliminando ... ha demostrado que es posible adquirir tolerancia oral ...
Breaking Medicine Technology:CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014 2Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3
... Conn., Sept. 16 Amarin Corporation plc (Nasdaq: ... is scheduled to present on Amarin,s behalf at the Global ... 12:30 pm. This conference will be held at the Grand ... appointed as President and Chief Executive Officer, will also be ...
... Wis., Sept. 16 Top researchers at the Gastrointestinal ... Dallas are exploring the clinical applications of BCM-95®, a ... bioavailability. Previous studies have shown that ... forms of curcumin, and had a retention time in ...
Cached Medicine Technology:Amarin to Present at UBS Life Sciences Conference 2BCM-95 Demonstrates Superior Anti-Inflammatory Effects 2
... day surgery and post anesthesia care in one ... is a high performance monitor designed for the ... and induction rooms. It offers the flexibility of ... advanced airway gas monitoring. When paired with the ...
... The complete picture of patient respiration and ... the most versatile respiration and ventilation monitors available. ... models. Each model allows you to measure the ... O 2 , and N 2 O easily ...
For accurately monitoring heart and breath sounds....
For accurately monitoring core temperature and heart and breath sounds....
Medicine Products: